- Project management for strategic analyses and preparations within the framework of the AMNOG process according to § 35a SGB V
- Strategic positioning of new products in the market environment and price negotiations according to § 130b SGB V
- Creating market environment analyses and price scenarios
- Identifying relevant comparative procedures, deriving learnings, and conducting strategy and simulation workshops to prepare for price negotiations
PROJECT MANAGER „MARKET ACCESS – PRICING“ (m/f/d)
SmartStep Consulting - Hamburg
Full or part-time
Permanent employee
Your mission
Your profile
- A degree in health economics, business administration, economics, medicine with a focus on pharmacology, pharmacy, psychology, or comparable sciences
- Several years of experience in conducting market access projects
- A high level of understanding of the German pharmaceutical market and interest in health policy and regulations
- Very good knowledge of the AMNOG process: methods of IQWiG, G-BA, requirements for price negotiations
- Strong interest in strategic analyses and cost calculations
- A high degree of initiative, commitment, and problem-solving ability, combined with a careful and reliable working style in a dynamic team
- Fluent English in spoken and written form and proficient use of MS Office
- Solid negotiation experience, project management experience, and interpersonal skills
Why us?
We offer you the opportunity to work in a dynamic and highly qualified team, exciting and varied projects in one of the ‘hot topics’ of healthcare, as well as performance-based remuneration. Additionally, we enable targeted employee development, further training through our own SmartStep Academy, and the continuous development of your personal skills.
About us
SmartStep Consulting offers customized, highly specialized services for the pharmaceutical and medical technology industries to enable patients quick access to new and better treatment options. As part of the G&L Group, SmartStep aims to expand its services and leverage international opportunities arising from the new EU-HTA procedures.